Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINITE CHB: Stopping TDF in Chronic Hepatitis B
NCT01320943Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2011
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Apr 2011; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01320943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320943.